Replies to post #3231 on Biotech Values

[rkrw]

You're correct about ADHD. I scanned the PR. Could be a dosing issue, they under dosed before? Either way, imo this is a big deal for ceph. Early filing and differentiating the single isomer into a new indication is VERY good news for ceph.